Adherium Targets U.S. Market for Growth Amid Revenue Dip
Company Announcements

Adherium Targets U.S. Market for Growth Amid Revenue Dip

Adherium Ltd. (AU:ADR) has released an update.

Adherium Limited reported a decrease in revenue by 73.7% and a slight increase in losses compared to the previous year. The company is focused on expanding its remote patient monitoring services in the U.S. healthcare market, aiming for cash flow positivity. Their new strategy involves partnering with U.S. health entities, enhancing patient adherence and proper inhaler use through remote monitoring to improve the quality of life for asthma sufferers.

For further insights into AU:ADR stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App